• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初级保健中外周动脉疾病二级预防的审计-血管外科和全科医生之间加强合作的空间。

An audit of secondary prevention for peripheral arterial disease in primary care - scope for improved collaboration between vascular surgery and general practitioners.

机构信息

Department of Vascular Surgery, University College Hospital Galway, Newcastle Road, Dublin 8, Dublin, H91YR71, Ireland.

School of Medicine, University of Galway, Galway, Ireland.

出版信息

Ir J Med Sci. 2023 Dec;192(6):3007-3010. doi: 10.1007/s11845-023-03362-1. Epub 2023 Apr 26.

DOI:10.1007/s11845-023-03362-1
PMID:37099256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10692140/
Abstract

BACKGROUND

Symptomatic peripheral arterial disease (PAD) is a common cause for referral from primary care to vascular surgery. Best medical therapy (BMT), encompassing anti-platelets, statins, smoking cessation, blood pressure and glycaemic control, is a cornerstone of PAD management. However, these easily modifiable risk factors are often left unaddressed between referral and clinic review.

METHODS

A prospective audit of electronic 'Healthlink' referrals by GPs to the vascular department for symptomatic PAD between July 2021 and June 2022 was performed. Referrals were individually reviewed for demographics, symptoms, medical history, smoking status and medications. An information leaflet on BMT was posted to all GP practices in the Soalta region as part of an educational intervention, with plans to re-audit after 6 months.

RESULTS

One-hundred-and-seventy referrals were analysed. The median age was 68.5 years (range 33-94) and 69% (n = 117) were male. The typical vasculopath comorbidity profile was noted. Fifty-two percent (n = 88) were referred with claudication-type pain and 25% (n = 43) with critical limb ischaemia (CLI). Twenty-eight percent (n = 33) were active smokers and 31% (n = 36) had no smoking status documented. Regarding BMT, only 34.5% (n = 40) and 52% (n = 60) were on anti-platelets and statins, respectively. Suspected CLI was not significantly associated with BMT prescription at referral (p = 0.664). Only eleven referral letters mentioned risk factor optimisation.

CONCLUSIONS

Our first-cycle results identified significant scope for improvement in community-based risk factor modification for PAD referrals. We aim to continue supporting and educating our colleagues that effective medical management can start safely in primary care and further explore the barriers preventing this.

摘要

背景

有症状的外周动脉疾病(PAD)是从初级保健向血管外科转诊的常见原因。最佳药物治疗(BMT)包括抗血小板药物、他汀类药物、戒烟、血压和血糖控制,是 PAD 管理的基石。然而,这些易于改变的危险因素在转诊和临床复查之间往往得不到解决。

方法

对 2021 年 7 月至 2022 年 6 月期间,全科医生通过电子“Healthlink”向血管科转诊的有症状 PAD 的患者进行了前瞻性审核。对转诊患者的人口统计学、症状、病史、吸烟状况和药物使用情况进行了单独审查。作为教育干预的一部分,向索尔塔地区的所有全科医生诊所发放了一份关于 BMT 的信息传单,并计划在 6 个月后重新审核。

结果

共分析了 170 份转诊记录。中位年龄为 68.5 岁(范围 33-94 岁),69%(n=117)为男性。注意到典型的血管病变合并症谱。52%(n=88)因跛行性疼痛而转诊,25%(n=43)因严重肢体缺血(CLI)而转诊。28%(n=33)为现吸烟患者,31%(n=36)的吸烟状况未记录。关于 BMT,分别只有 34.5%(n=40)和 52%(n=60)的患者接受了抗血小板和他汀类药物治疗。疑似 CLI 与转诊时 BMT 处方无显著相关性(p=0.664)。只有 11 封转诊信提到了危险因素优化。

结论

我们的第一轮结果发现,在社区为 PAD 转诊患者进行危险因素改变方面有很大的改进空间。我们旨在继续支持和教育我们的同事,安全地在初级保健中开始有效的药物治疗,并进一步探索阻碍这一治疗的因素。

相似文献

1
An audit of secondary prevention for peripheral arterial disease in primary care - scope for improved collaboration between vascular surgery and general practitioners.初级保健中外周动脉疾病二级预防的审计-血管外科和全科医生之间加强合作的空间。
Ir J Med Sci. 2023 Dec;192(6):3007-3010. doi: 10.1007/s11845-023-03362-1. Epub 2023 Apr 26.
2
Limited Adherence to Peripheral Arterial Disease Guidelines and Suboptimal Ankle Brachial Index Reliability in Dutch Primary Care.荷兰初级保健中,外周动脉疾病指南的遵循情况有限,踝臂指数的可靠性也不理想。
Eur J Vasc Endovasc Surg. 2018 Jun;55(6):867-873. doi: 10.1016/j.ejvs.2018.02.011. Epub 2018 Mar 23.
3
4
Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.转诊至英国血管诊所的外周动脉疾病患者的特征与治疗:一项前瞻性登记研究结果
Eur J Vasc Endovasc Surg. 2007 Apr;33(4):442-50. doi: 10.1016/j.ejvs.2006.11.010. Epub 2006 Dec 29.
5
Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.有症状外周动脉疾病血运重建患者他汀类药物和抗血小板治疗使用不充分的危险因素
Ann Vasc Surg. 2018 Jan;46:234-240. doi: 10.1016/j.avsg.2017.05.030. Epub 2017 Jun 8.
6
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.接受血运重建的外周动脉疾病患者的当代心血管风险及二级预防药物治疗模式
J Vasc Surg. 2016 Oct;64(4):1009-1017.e3. doi: 10.1016/j.jvs.2016.03.429. Epub 2016 May 18.
7
The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.初次血管重建术后二级医疗预防的应用:使用情况及有效性研究
Dan Med J. 2012 Sep;59(9):B4514.
8
Optimal medical management before lower extremity bypass for claudication in the veteran population.下肢跛行患者行下肢旁路术前的最佳医学管理。
J Vasc Surg. 2019 Feb;69(2):545-554. doi: 10.1016/j.jvs.2018.05.222. Epub 2018 Aug 11.
9
Underutilization of medical management of peripheral artery disease among patients with claudication undergoing lower extremity bypass.下肢旁路术后跛行患者外周动脉疾病的医学管理未得到充分利用。
J Vasc Surg. 2022 Oct;76(4):1037-1044.e2. doi: 10.1016/j.jvs.2022.05.016. Epub 2022 Jun 14.
10
Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.下肢动脉血运重建术后4年遵循指南推荐治疗对死亡率和心血管事件的影响
Ann Vasc Surg. 2018 Oct;52:138-146. doi: 10.1016/j.avsg.2018.03.021. Epub 2018 May 17.

本文引用的文献

1
Poor patient awareness of peripheral arterial disease, it is time to optimize the clinical visit.患者对周围动脉疾病的认识较差,是时候优化临床就诊了。
Surgeon. 2022 Jun;20(3):157-163. doi: 10.1016/j.surge.2021.03.009. Epub 2021 Jun 18.
2
Epidemiology of Peripheral Artery Disease and Polyvascular Disease.外周动脉疾病和多血管疾病的流行病学。
Circ Res. 2021 Jun 11;128(12):1818-1832. doi: 10.1161/CIRCRESAHA.121.318535. Epub 2021 Jun 10.
3
Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates.间歇性跛行患者的血运重建会导致更多的慢性肢体威胁性缺血和更高的截肢率。
J Vasc Surg. 2021 Sep;74(3):771-779. doi: 10.1016/j.jvs.2021.02.045. Epub 2021 Mar 26.
4
Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.丹麦外周动脉疾病血运重建术后二级预防和心血管结局的时间变化:一项全国性队列研究。
Circulation. 2021 Mar 2;143(9):907-920. doi: 10.1161/CIRCULATIONAHA.120.047994. Epub 2020 Dec 10.
5
Multiple Reinterventions for Claudication are Associated with Progression to Chronic Limb-Threatening Ischemia.对于间歇性跛行的多次再介入与进展为慢性肢体威胁性缺血相关。
Ann Vasc Surg. 2021 Apr;72:166-174. doi: 10.1016/j.avsg.2020.10.004. Epub 2020 Nov 21.
6
Peripheral artery disease in the lower limbs: The importance of secondary risk prevention for improved long-term prognosis.下肢外周动脉疾病:二级预防对改善长期预后的重要性。
Aust J Gen Pract. 2020 May;49(5):239-244. doi: 10.31128/AJGP-11-19-5160.
7
Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.间歇性跛行患者血管重建术无长期获益:IRONIC 随机对照试验 5 年结果。
Circ Cardiovasc Interv. 2020 Jan;13(1):e008450. doi: 10.1161/CIRCINTERVENTIONS.119.008450. Epub 2020 Jan 15.
8
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).编辑推荐——2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南
Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368. doi: 10.1016/j.ejvs.2017.07.018. Epub 2017 Aug 26.
9
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 年美国心脏协会/美国心脏病学会下肢外周动脉疾病管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2017 Mar 21;135(12):e686-e725. doi: 10.1161/CIR.0000000000000470. Epub 2016 Nov 13.
10
Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.指南推荐的降低风险方案对改善外周动脉疾病患者心血管和肢体结局的疗效。
JAMA Surg. 2016 Aug 1;151(8):742-50. doi: 10.1001/jamasurg.2016.0415.